Sdc1 overexpression inhibits the p38 MAPK pathway and lessens fibrotic ventricular remodeling in MI rats

Inflammation

Volumn 36, Issue 3, 2013, Pages 603-615

  Lei, Juan ^a   Xue, Shengneng ^b   Wu, Wei ^a   Zhou, Shuxian ^a   Zhang, Yuling ^a   Yuan, Guiyi ^a   Wang, Jingfeng ^a  

^a SUN YAT SEN MEMORIAL HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

myocardial infarction; P38 MAPK; syndecan 1; ventricular remodeling

Indexed keywords

ADENOVIRUS VECTOR; COLLAGEN TYPE 1; COLLAGEN TYPE 3; GREEN FLUORESCENT PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; SODIUM CHLORIDE; SYNDECAN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DRUG EFFECT; GENE OVEREXPRESSION; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART VENTRICLE REMODELING; HEART WEIGHT; IN VIVO GENE TRANSFER; INFLAMMATION; INFLAMMATORY INFILTRATE; MALE; NONHUMAN; PROTEIN CONTENT; RAT; SIGNAL TRANSDUCTION;

ADENOVIRIDAE; ANIMALS; APOPTOSIS; FIBROSIS; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; INFLAMMATION; MALE; MAP KINASE SIGNALING SYSTEM; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RATS; RATS, SPRAGUE-DAWLEY; SYNDECAN-1; VENTRICULAR REMODELING;

ADENOVIRIDAE; RATTUS;

EID: 84877737590     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-012-9582-y     Document Type: Article

References (32)

1. Alexopoulou, A.N., H.A.B. Multhaipt, and J.R. Couchman. 2006. Syndecans in wound healing, inflammation and vascular biology. The International Journal of Biochemistry & Cell Biology 39: 505-528.
2. Lei, J., S.N. Xue, W. Wu, S.X. Zhou, Y.L. Zhang, G.Y. Yuan, and J.F. Wang. 2012. Increased level of soluble syndecan-1 in serum correlated with cardiac expression in a rat model of myocardial infarction. Molecular and Cellular Biochemistry 359: 177-182.
3. Vanhoutte, D., M.W. Schellings, M. Götte, M. Swinnen, V. Herias, M.K. Wild, et al. 2007. Increased expression of syndecan-1 protects against cardiac dilatation and dysfunction after myocardial infarction. Circulation 115: 475-482.
4. Landau, C., M.J. Pirwitz, M.A. Willard, et al. 1995. Adenoviral mediated gene transfer to atherosclerotic arteries after balloon angioplasty. American Heart Journal 129: 1051-1057.
5. Lei, J., W. Wu, S.N. Xue, and S.X. Zhen. 2009. Establishment and assessment of a rat experimental model of acute myocardial infarction. China Practical Medicine (Chin) 4: 1-3.
6. Zhang, J., M.X. Xie, X.F. Wang, et al. 2006. Effects of myocardial cell transplantation on the left ventricular remodeling and cardiac function in Wistar rats after myocardial infarction assessed by echocardiography. Chin J Ultrasonography 15(3): 216-219.
7. Hu, Z.Y., N.F. Luo, and J. Liu. 2009. The protective effects of emulsified isoflurane on myocardial ischemia and reperfusion injury in rats. Canadian Journal of Anaesthesia 56(2): 115-125.
8. Pieruzzi, F., Z.A. Abassi, and H.R. Keiser. 1995. Expression of renin-angiotensin system components in the heart, kidneys, and lungs of rats with experimental heart failure. Circulation 92: 3105-3112.
9. Gulati, S.C., D.L. Kacian, and S. Spiegelman. 1974. Conditions for using DNA polymerase I as an RNA-dependent DNA polymerase. Proceedings of the National Academy of Sciences of the United States of America 71: 035-1039.
10. Zhang, Y.L., S.X. Zhou, J. Lei, G.Y. Yuan, and J.F. Wang. 2008. Blockades of angiotensin and aldosterone reduce osteopontin expression and interstitial fibrosis infiltration in rats with myocardial infarction. Chinese Medical Journal 121: 2192-2196.
11. Wang, J.B., J. Guan, J. Shen, L. Zhou, Y.J. Zhang, Y.F. Si, et al. 2008. Insulin increases shedding of syndecan-1 in the serum of patients with type 2 diabetes mellitus. Diabetes Research and Clinical Practice 86: 83-88.
12. Infanger, M., J. Grosse, K. Westphal, et al. 2008. Vascular endothelial growth factor induces extracellular matrix proteins and osteopontin in the umbilical artery. Annals of Vascular Surgery 22: 273-284.
13. Xu, H., F. Noria, M.J. Sandoval-Cooper, et al. 2009. Severe deficiency of coagulation Factor VII results in spontaneous cardiac fibrosis in mice. The Journal of Pathology 217: 362-371.
14. Mizoquchi, K., H. Maeta, A. Yamamoto, et al. 2002. Amelioration of myocardial global ischemia/reperfusion injury with volume-regulatory chloride channel inhibitors in vivo. Transplantation 73: 1185-1193.
15. Rhodes, N.P., C.D. Bartolo, and J.A. Hunt. 2007. Analysis of the cellular infiltration of benzyl-esterified hyaluronan sponges implanted in rats. Biomacromolecules 8: 2733-2738.
16. Frantz, S., J. Bauersachs, and G. Ertl. 2009. Post-infarct remodelling: Contribution of wound healing and inflammation. Cardiovascular Research 81: 474-481.
17. Takenaka, H., M. Horiba, H. Ishiguro, et al. 2009. Midkine prevents ventricular remodeling and improves long-term survival after myocardial infarction. American Journal of Physiology. Heart and Circulatory Physiology 296: H462-H469.
18. Choi, D.S., J.H. Kim, H.S. Ryu, et al. 2007. Syndecan-1, a key regulator of cell viability in endometrial cancer. International Journal of Cancer 121: 741-750.
19. Abbate, A., F.N. Salloum, E. Vecile, et al. 2008. Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction. Circulation 117: 2670-2683.
20. Mann, D.L., and H. Taegtmeyer. 2001. Dynamic regulation of the extracellular matrix after mechanical unloading of the failing human heart: Recovering the missing link in left ventricular remodeling. Circulation 104: 1089-1091.
21. Ishii, H., T. Amano, T. Matsubara, et al. 2008. Pharmacological intervention for prevention of left ventricular remodeling and improving prognosis in myocardial infarction. Circulation 118: 2710-2718.
22. Sun, Y. 2009. Myocardial repair/remodelling following infarction: Roles of local factors. Cardiovascular Research 81: 482-490.
23. Weber, K.T. 1989. Cardiac interstitium in health and disease: The fibrillar collagen network. Journal of the American College of Cardiology 13: 1637-1652.
24. Zheng, X., T. Zhang, Y. Qin, et al. 1999. Interstitial remodeling of the infarcted area and the non-infarcted area in rats after myocardial infarction. Transact. Second Military Med. Univ. 20: 662-665.
25. Wei, S., L.T. Chow, I.O. Sham, et al. 1999. Left and right ventricular collagen type I/III ratios and remodeling post-myocardial infarction. Journal of Cardiac Failure 5: 117-126.
26. Raake, P., G. von Degenfeld, R. Hinkel, et al. 2004. Myocardial gene transfer by selective pressure-regulated retroinfusion of coronary veins: Comparison with surgical and percutaneous intramyocardial gene delivery. Journal of the American College of Cardiology 44: 1124-1129.
27. Hunter, J.J., and K.R. Chien. 1999. Signal pathways for cardiac hypertrophy and failure. The New England Journal of Medicine 341: 1276-1283.
28. Yin, H., J. Zhang, H. Lin, et al. 2008. P38 mitogen-activated protein kinase inhibition decreases TNFalpha secretion and protects against left ventricular remodeling in rats with myocardial ischemia. Inflammation 31: 65-73.
29. Ren, J., S. Zhang, A. Kovacs, et al. 2005. Role of p38alpha MAPK in cardiac apoptosis and remodeling after myocardial infarction. Journal of Molecular and Cellular Cardiology 38: 617-623.
30. Matsuoto-Ida, M., Y. Takimoto, T. Aoyama, M. Akao, T. Takda, and T. Kita. 2006. Activation of TGF-β1-TAK1-p38 MAPK pathway in spared cardiomyocytes is involved in left ventricular remodeling after myocardial infarction in rats. American Journal of Physiology. Heart and Circulatory Physiology 290: H709-H715.
31. Jaakkola, P., S. Kontusaari, T. Kauppi, et al. 1998. Wound reepithelialization activates a growth factor-responsive enhancer in migrating keratinocytes. The FASEB Journal 12: 959-969.
32. Popova, T.G., B. Millis, C. Bradburne, et al. 2006. Acceleration of epithelial cell syndecan-1 shedding by anthrax hemolytic virulence factors. BMC Microbiology 6: 8.